• 1
    Mohammed D, Matts PJ, Hadgraft J, Lane ME. Influence of aqueous cream BP on corneocyte size, maturity, skin protease activity, protein content and transepidermal water loss. Br J Dermatol 2011; 164:130410.
  • 2
    Tsang M, Guy RH. Effect of aqueous cream BP on human stratum corneum in vivo. Br J Dermatol 2010; 163:9548.
  • 3
    British Pharmacopoeia. London: The Pharmaceutical Press, 1958.
  • 4
    Tupker RA, Willis C, Berardesca E et al. Guidelines on sodium lauryl sulfate (SLS) exposure tests. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1997; 37:5369.
  • 5
    Fluhr J, Bankova LG. Skin surface pH: mechanism, measurement, importance. In: Handbook of Non-Invasive Methods and the Skin (SerupJ, JemecGB, GroveGL, eds). Boca Raton: CRC Press, 2006; 41120.
  • 6
    Gloor M. How do dermatological vehicles influence the horny layer? Skin Pharmacol Physiol 2004; 17:26773.
  • 7
    Hachem JP, Crumrine D, Fluhr J et al. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 2003; 121:34553.
  • 8
    Danby S, Cork MJ. A new understanding of atopic dermatitis: the role of epidermal barrier dysfunction and subclinical inflammation. J Clin Dermatol 2010; 1:3346.
  • 9
    Cork MJ, Danby SG, Vasilopoulos Y et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 2009; 129:1892908.
  • 10
    Batchelor JM, Grindlay DJ, Williams HC. What’s new in atopic eczema? An analysis of systematic reviews published in 2008 and 2009 Clin Exp Dermatol 2010; 35:8237.
  • 11
    Lewis-Jones S, Cork MJ, Clark C et al. Atopic Eczema in Children – Guideline Consultation: A Systematic Review of the Treatments for Atopic Eczema and Guideline for its Management. London: National Institute for Clinical Excellence (NICE), 2007.
  • 12
    Cork MJ, Danby S. Skin barrier breakdown: a renaissance in emollient therapy. Br J Nurs 2009; 4:67.
  • 13
    NHS Information Centre Prescribing Support Unit. Prescription Cost Analysis England 2009. London: NHS Information Centre for Health and Social Care, 2010.
  • 14
    Al Enezi T, Sultan A, Chittock J et al. Breakdown of the skin barrier induced by aqueous cream: implications for the management of atopic eczema. Br J Dermatol 2009; 161 (Suppl. 1):11516. (Abstract).
  • 15
    Cork MJ, Timmins J, Holden C et al. An audit of adverse drug reactions to aqueous cream in children with atopic eczema. Pharm J 2003; 271:7467.
  • 16
    Wiren K, Nohlgard C, Nyberg F et al. Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial. J Eur Acad Dermatol Venereol 2009; 23:126772.
  • 17
    Reissell E, Herse F, Vaananen J et al. Asthma costs in Finland 1987–2005: a public health model to indicate cost effectiveness during 20 years. Fin Med J 2010; 65:81116.